By Business/Source
Currency:USD
2026/Q3
Stock NameRevenueRatio
Pocono Pharmaceuticals346.06K100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States2.14M100.00%